The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
25.86
+0.29 (1.13%)
Oct 3, 2025, 4:00 PM EDT - Market closed
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $893.77 million as of October 3, 2025. Its market cap has decreased by -15.44% in one year.
Market Cap
893.77M
Enterprise Value
1.20B
1-Year Change
-15.44%
Ranking
Category
Stock Price
$25.86
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.52M to $893.77M, an increase of 111.53%. That is a compound annual growth rate of 13.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 893.77M | -1.88% |
| Dec 31, 2024 | 910.92M | 118.67% |
| Dec 29, 2023 | 416.58M | 27.84% |
| Dec 30, 2022 | 325.85M | -50.42% |
| Dec 31, 2021 | 657.25M | -59.84% |
| Dec 31, 2020 | 1.64B | 77.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |